SPARC and prostate cancer: As prostate cancer bone metastasis is considered as a microenvironment-driven disease, the higher levels of osteonectin expressed by human bone stromal cells than that of prostate cancer cells was observed using hFOB osteoblast and HS27A bone marrow derived fibroblast cell lines (Fig 1A).